Published: September 10, 2007
Fibromyalgia Awareness Week – UK Sept 8-15Â
This week is Fibromyalgia Awareness Week and as support groups up and down the country gather to gain more recognition of the condition it has been revealed that Dr Kim Lawson, a senior lecturer in pharmacology at the university, has put forward a submission to NICE (National Institute for Health and Clinical Excellence), in collaboration with the Fibromyalgia Association UK, for the development of diagnostic and treatment guidelines.
Currently there is no cure for fibromyalgia, which is thought to affect up to four per cent of the population, and treating patients leads to high costs not only for the NHS but also for sufferers who are forced to go private for some treatments. [continue reading…]
Published: September 10, 2007
Facebook the social networking site that started off as a Web site that allowed college students to keep tabs on each other does not help you make more genuine close friends according to a current research study.
[continue reading…]
Published: September 10, 2007
A new initiative to help make schoolchildren happier and healthier has been launched in Great Britain. Experts from psychology and education at Sheffield Hallam University are working with schools and some children’s services in the region to create special programmes to look after youngsters’ mental health and well-being.
The most recent survey concerning children’s mental health indicated that one in ten children aged five to 16 have a clinically recognised disorder, such as anxiety, depression, attention deficit disorders and autism. That translates to 6000 children alone in the Sheffield area. [continue reading…]
Published: September 10, 2007
— may one day offer an alternative to antipsychotic
© Getty Images
Toronto, ONT – Researchers have found surprising evidence that an antidepressant (citalopram) may perform as well as a commonly-prescribed antipsychotic (risperidone) in the alleviation of severe agitation and psychotic symptoms of dementia. Researchers also found that the antidepressant was associated with “significantly lower” adverse side effects.
The study, published in the online American Journal of Geriatric Psychiatry (in advance of the November 2007 issue), is believed to be the first head-to-head comparison of an SSRI (selective serotonin reuptake inhibitor) with one of the more commonly prescribed second generation antipsychotics in older, non-depressed patients. [continue reading…]
